3.58 USD
↗ 0.18 (5.15%)PRE MARKET (AS OF 07:20 AM EDT)
Briacell Therapeutics Corp. Common Shares
BCTXNASDAQ • USD
Market: OPEN
Shares of Briacell Therapeutics Corp. Common Shares (BCTX) are trading at $3.58. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 16, 2026.
Open?$3.57
High?$3.58
Low?$3.57
Prev. Close?$3.40
Volume?53
Avg. Volume?120.8K
VWAP?$3.58
Rel. Volume?0.00x
Bid / Ask
Bid?$2.91 × 100
Ask?$4.10 × 100
Spread?$1.19
Midpoint?$3.51
Valuation & Ratios
Market Cap?29.6M
Shares Out?N/A
Float?8.5M
Float %?97.9%
P/E Ratio?N/A
P/B Ratio?1.23
EPS?-$3.53
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
WEST VANCOUVER, A1 V7T 2X1
Phone: (604) 921-1810
WEST VANCOUVER, A1 V7T 2X1
Phone: (604) 921-1810
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?60
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.04Distress
Confidence?44%Low
Short InterestElevated
Short % of Float?9.15%Elevated
Short Interest?779.1K
Days to Cover?3.9
Free Float8.5M
Avg Daily Volume200.4K
Settlement Date2026-09-30
Financial Health
Current Ratio?7.07Strong
Quick Ratio?7.07Strong
Cash Ratio?1.92Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.23CHEAP▾
Peers100
S&P93
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-127.5%WEAK▾
S&P3
ROA?-113.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-30951946
Enterprise Value?$22.7M
Fundamentals ratios updated end of day